Login Preferences
About News Publications Statistics Downloads API Guide License How to use Preferences
bn:03457824n
Noun Concept
SYL
No term available
EN
Ranibizumab, sold under the brand name Lucentis among others, is a monoclonal antibody fragment created from the same parent mouse antibody as bevacizumab. Wikipedia
Relations
Sources
IS A
EN
compound
EN
medicine
EN
monoclonal antibody
EN
biopharmaceutical
HAS PART
EN
carbon
MEDICAL CONDITION TREATED
EN
diabetic retinopathy
EN
eye disease
EN
glaucoma
EN
macular edema
EN
retinopathy
ROUTE OF ADMINISTRATION
EN
intravitreal administration
SUBJECT HAS ROLE
EN
angiogenesis inhibitor

Please note that, in order to improve your browsing experience on this website, BabelNet® uses various types of cookies, including: browsing functionality, performance and statistical cookies.

By continuing to browse the site you are agreeing to our use of cookies. OK

License